Download | < Back |
13 Aug 2024 | |
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Unaudited Financial Results for the quarter ended June 30, 2024, along with the Limited Review Reports on the aforesaid results as issued by the B S R & Co. LLP, Chartered Accountants, Auditors of the Company, enclosed as Annexure A. Press Release outlining key updates on the aforesaid results are enclosed as Annexure B. | |
View all announcements for Emcure Pharmaceuticals Ltd | Source: BSE India |